Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study.
暂无分享,去创建一个
R. D'Agostino | E. Benjamin | R. Vasan | S. Booth | S. Kathiresan | J. Massaro | C. O’Donnell | J. Ordovás | J. Keaney | B. Dawson-Hughes | P. Jacques | M. Shea
[1] S. Booth,et al. Role of vitamin K in the regulation of calcification , 2007 .
[2] J. Hansen,et al. Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans. , 2005, Atherosclerosis.
[3] F. Hu,et al. Phylloquinone intake and risk of cardiovascular diseases in men. , 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[4] J. Myśliwska,et al. Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries. , 2006, European cytokine network.
[5] C. Christiansen,et al. Radiographic measure of aorta calcification is a site‐specific predictor of bone loss and fracture risk at the hip , 2006, Journal of internal medicine.
[6] R. D'Agostino,et al. Relations of inflammation and novel risk factors to valvular calcification. , 2006, The American journal of cardiology.
[7] R. D'Agostino,et al. Association of educational level with inflammatory markers in the Framingham Offspring Study. , 2006, American journal of epidemiology.
[8] G. Tenderich,et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.
[9] Peter Libby,et al. Inflammation and cardiovascular disease mechanisms. , 2006, The American journal of clinical nutrition.
[10] Yusuke Ohsaki,et al. Vitamin K Suppresses Lipopolysaccharide-Induced Inflammation in the Rat , 2006, Bioscience, biotechnology, and biochemistry.
[11] D. Kiel,et al. Bone loss and the progression of abdominal aortic calcification over a 25 year period: The Framingham heart study , 2001, Calcified Tissue International.
[12] B. Riggs,et al. The role of the immune system in the pathophysiology of osteoporosis , 2005, Immunological reviews.
[13] C. Mathieu,et al. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[14] R. Koerfer,et al. Putting cardiovascular disease and vitamin D insufficiency into perspective , 2005, British Journal of Nutrition.
[15] A. Lin,et al. Antioxidative Effect of Vitamin D3 on Zinc‐Induced Oxidative Stress in CNS , 2005, Annals of the New York Academy of Sciences.
[16] M. Fukunaga,et al. Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells. , 2005, International journal of molecular medicine.
[17] G. Vigna,et al. Testosterone replacement, cardiovascular system and risk factors in the aging male. , 2005, Journal of endocrinological investigation.
[18] M. Mastropasqua,et al. Cardiovascular disease and osteoporosis. , 2005, Journal of endocrinological investigation.
[19] M. Holick. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. , 2004, The American journal of clinical nutrition.
[20] K. Özoran,et al. The Effects of Calcitriol Therapy on Serum Interleukin-1, Interleukin-6 and Tumour Necrosis Factor-α Concentrations in Post-menopausal Patients with Osteoporosis , 2004, The Journal of international medical research.
[21] D. Kiel,et al. Associations between vitamin K biochemical measures and bone mineral density in men and women. , 2004, The Journal of clinical endocrinology and metabolism.
[22] P. Wilson,et al. Dietary phylloquinone intake as a potential marker for a heart-healthy dietary pattern in the Framingham Offspring cohort. , 2004, Journal of the American Dietetic Association.
[23] L. Hofbauer,et al. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. , 2004, JAMA.
[24] H. Bischoff-Ferrari,et al. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. , 2004, The American journal of medicine.
[25] Kwan Tat Steeve,et al. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. , 2004 .
[26] S. Kwan Tat,et al. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. , 2004, Cytokine & growth factor reviews.
[27] Y. Asano,et al. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG) , 2004, Journal of Bone and Mineral Metabolism.
[28] R. Detrano,et al. Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Gannagé-Yared,et al. Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women , 2003, Journal of endocrinological investigation.
[30] Hong Wang,et al. Novel Role of Vitamin K in Preventing Oxidative Injury to Developing Oligodendrocytes and Neurons , 2003, The Journal of Neuroscience.
[31] E. Benjamin,et al. Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[32] L. Hofbauer,et al. Increased osteoprotegerin serum levels in men with coronary artery disease. , 2003, The Journal of clinical endocrinology and metabolism.
[33] F. Cosman,et al. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation , 2003, Journal of Neuroimmunology.
[34] D. Kiel,et al. Dietary and nondietary determinants of vitamin K biochemical measures in men and women. , 2002, The Journal of nutrition.
[35] B. Dawson-Hughes,et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. , 2002, Bone.
[36] K. Preissner,et al. RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[37] William Maloney,et al. Receptor Activator of NF-κB and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human Osteoclastogenesis* , 2001, The Journal of Biological Chemistry.
[38] K. Ikeda,et al. Immunological Characterization of Circulating Osteoprotegerin/Osteoclastogenesis Inhibitory Factor: Increased Serum Concentrations in Postmenopausal Women with Osteoporosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] C. Tetta,et al. Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium. , 1998, Kidney international.
[40] C. Gundberg,et al. Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. , 1998, The Journal of clinical endocrinology and metabolism.
[41] K Yano,et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[42] R. Heaney,et al. Vitamin D and its Major Metabolites: Serum Levels after Graded Oral Dosing in Healthy Men , 1998, Osteoporosis International.
[43] B. Dawson-Hughes,et al. Nutritional Aspects of Osteoporosis , 1998, Proceedings in the Serono Symposia USA Series.
[44] P. Wilson,et al. Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample. , 1997, The American journal of clinical nutrition.
[45] J. Sadowski,et al. Determination of vitamin K compounds in plasma or serum by high-performance liquid chromatography using postcolumn chemical reduction and fluorimetric detection. , 1997, Methods in enzymology.
[46] B. Henderson,et al. Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. , 1995, Cytokine.
[47] M. Shiraki,et al. Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activity. , 1993, Biochemical pharmacology.
[48] A. Kharazmi,et al. 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. , 1992, Cytokine.
[49] P. Allhoff,et al. The Framingham Offspring Study , 1991 .
[50] P. Garry,et al. Phylloquinone in plasma from elderly and young adults: factors influencing its concentration. , 1989, The American journal of clinical nutrition.
[51] W. Willett,et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. , 1985, American journal of epidemiology.
[52] J. Lian,et al. Osteocalcin: isolation, characterization, and detection. , 1984, Methods in enzymology.
[53] W. Kannel,et al. An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.
[54] A. Clauss,et al. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .
[55] A. Clauss. [Rapid physiological coagulation method in determination of fibrinogen]. , 1957, Acta haematologica.